Cargando…
Insulin resistance and inflammation markers in myocardial infarction
BACKGROUND: Insulin resistance (IR) is known to be characteristic of type 2 diabetes mellitus, and is regarded as an important mechanism in disease pathogenesis. One of the key pathogenetic mechanisms of IR progression is impaired free fatty acid (FFA) metabolism. Plasminogen-activator inhibitor 1 (...
Autores principales: | Gruzdeva, Olga, Uchasova, Evgenya, Dyleva, Yulia, Belik, Ekaterina, Shurygina, Ekaterina, Barbarash, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699291/ https://www.ncbi.nlm.nih.gov/pubmed/23837002 http://dx.doi.org/10.2147/JIR.S43081 |
Ejemplares similares
-
Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance
por: Gruzdeva, Olga, et al.
Publicado: (2014) -
Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2013) -
Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure
por: Gruzdeva, Olga, et al.
Publicado: (2013) -
Dose-dependent effects of atorvastatin on myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2015) -
Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
por: Barbarash, Olga, et al.
Publicado: (2017)